EP2872491
HEMLAR VAXTARÞÁTTARVIÐTAKA TREFJAKÍMFRUMNA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.7.2013EP published:
5.5.2021EP application number:
13740458.8
EP translation filed:
26.7.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
10.7.2033Expiry date:
10.7.2026Next due date:
31.7.2026
Title:
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
Timeline
Today
11.7.2013EP application
5.5.2021EP Publication
26.7.2021Translation submitted
15.9.2021Registration published
10.7.2026Expires
Owner
Name:
Blueprint Medicines CorporationAddress:
45 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
BIFULCO, Neil, Jr.Address:
Sudbury, MA 01776, US
Name:
BROOIJMANS, NatasjaAddress:
Boston, MA 02118, US
Name:
HODOUS, Brian, L.Address:
Cambridge, MA 02139, US
Name:
KIM, Joseph, L.Address:
Wayland, MA 01778, US
Name:
MIDUTURU, Chandrasekhar, V.Address:
Cambridge, MA 02138, US
Name:
WENGLOWSKY, Steven MarkAddress:
Somerville, MA 02143, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261670379 PDate:
11.7.2012Country:
US
Number:
201261746666 PDate:
28.12.2012Country:
US
Classification
Categories:
C07D 239/42, C07D 239/84, C07D 471/04, C07D 475/00, C07D 487/04, A61K 31/437, A61K 31/505, A61K 31/506, A61K 31/517, A61K 31/519, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.8.2021
Expires: 10.7.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 9.6.2022
Expires: 10.7.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.6.2023
Expires: 10.7.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 6.6.2024
Expires: 10.7.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 18.7.2025
Expires: 10.7.2026
Payer: Árnason Faktor ehf.